Facilitated By

San Antonio Medical Foundation

A Collaboration of the San Antonio Bioscience and Medical Research Community

A first-of-its-kind initiative between public and private sector to catalog and highlight Bioscience research in the city of San Antonio and the surrounding areas.

Trending Research

Top viewed research performed by San Antonio Bioscience Organizations

DECON
59th Medical Wing at the Wilford Hall Ambulatory Surgical Center (WHASC)
Chagoy
More Info
A Phase 3, Multinational, Double-Blind, Randomized, Placebo-Controlled Study Of MGL-3196 (Resmetirom) In Patients With Non-Alcoholic Steatohepatitis (NASH) To Resolve Nash And Reduce Progression To Cirrhosis And/Or Hepatic Decompensation

This is a multicenter, phase 3, double-blind, randomized, placebo-controlled study. Patients who qualify for study inclusion will be randomized in a 1:1:1 manner to receive MGL-3196 100 mg, MGL-3196 80 mg, or matching placebo given orally once daily in the morning for up to 54 months. If any patient has a Composite clinical outcome event on the Week 52 liver biopsy or any clinical composite event after Week 52 and prior to month 54 they will discontinue from the main study and will be allowed to participate in an open-label study on active treatment with MGL-3196.

Brooke Army Medical Center
More Info